Table 3.
Gender and type of donor in relation to presence of HBsAg, HBeAg, anti-HBe, HBV DNA, anti-HBs and anti-HBc as markers for past infection and anti-HBs alone as indication of HBV vaccination
| First time donors | Repeat donors | All donors | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Presence of marker | Males | Females | All | Males | Females | All | Males | Females | All |
| HBsAg (% of all 720 samples obtained) | 113 (15.7) | 18 (2.5) | 131 (18.2) | 7 (1.0) | 1 (0.1) | 8 (1.1) | 120 (16.7) | 19 (2.6) | 139 (19.3) |
| HBeAga (% of 132 HBsAg positive samples) | 27 (20.5) | 4 (3.0) | 31 (23.5) | 1 (0.8) | 0 | 1 (0.8) | 28 (21.2) | 4 (3.0) | 32 (24.2) |
| Anti-HBeb (% of 131 HBsAg positive samples) | 82 (62.6) | 14 (10.7) | 96 (73.3) | 5 (3.8) | 1 (0.8) | 6 (4.6) | 87 (66.4) | 15 (11.4) | 102 (77.9) |
| HBV DNA and HBeAg (% of HBeAg positive samples) | 26 (96.3) | 4 (100) | 30 (96.8) | 1 (100) | 0 | 1 (100) | 27 (96.4) | 4 (100) | 31 (96.9) |
| HBV DNA and anti-HBe (% of anti-HBe positive samples) | 40 (48.8) | 11 (78.6) | 51 (53.1) | 2 (40) | 0 | 2 (33) | 42 (48.3) | 11 (73.3) | 53 (52.0) |
| All with HBV DNA (% of 139HBsAg positive samples) | 67 (48.2) | 15 (10.8) | 82 (59.0) | 3 (2.2) | 0 | 3 (2.2) | 70 (50.4) | 15 (10.8) | 85 (61.2) |
| Anti-HBs and anti-HBc (% of 581 HBsAg negative) | 37 (0.6) | 11 (1.9) | 48 (8.3) | 66 (11.4) | 8 (1.4) | 74 (12.7) | 103 (17.7) | 19 (3.3) | 122 (21) |
| Anti-HBs lacking anti-HBc (% of 581 HBsAg negative) | 9 (1.5) | 3 (0.6) | 12 (2) | 11 (1.9) | 2 (0.3) | 13 (2.2) | 20 (3.4) | 5 (0.9) | 25 (4.3) |
a7 samples were not sufficient for HBeAg; b8 samples were not sufficient in material to run the anti-HBe